Company Filing History:
Years Active: 2007-2008
Title: Gérard Damien: Innovator in Pharmaceutical Patents
Introduction
Gérard Damien is a notable inventor based in Meung Sur Loire, France. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work primarily focuses on medicinal products that address critical health issues such as osteoporosis and bradycardia.
Latest Patents
Among his latest patents is the development of the alpha crystalline form of strontium ranelate. This invention is characterized by its powder X-ray diffraction diagram and a water content ranging from 22 to 24%. It is particularly useful in the treatment of osteoporosis and arthrosis. Another significant patent is the β-crystalline form of ivabradine hydrochloride, which includes a process for its preparation and pharmaceutical compositions containing it. This invention is characterized by its powder X-ray diffraction data and is beneficial as a bradycardic agent.
Career Highlights
Gérard Damien is associated with Les Laboratoires Servier, a prominent company in the pharmaceutical industry. His innovative work has contributed to the advancement of treatments that improve patient outcomes in various medical conditions.
Collaborations
He has collaborated with notable coworkers such as Stéphane Horvath and Marie-Noëlle Auguste, further enhancing the impact of his research and inventions.
Conclusion
Gérard Damien's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through his inventions. His patents reflect a deep understanding of medicinal chemistry and a dedication to addressing significant health challenges.